on March 4, 2026

By the Current Consulting Group

2026 State Cannabis & Psychedelic Legislation: What Employers Need to Know Now 

This information is provided for educational purposes only. Reader retains full responsibility for the use of the information contained herein.

The 2026 legislative session is shaping up to be one of the most consequential years yet for cannabis, hemp-derived cannabinoids, and even psilocybin policy. From expanded medical cannabis protections to explicit employer immunity provisions—and in some cases, broad anti-discrimination mandates—state lawmakers are redefining the balance between employee rights and workplace safety.

For employers, the message is clear: policy complacency is not an option.

The following highlights state-by-state breakdowns of some of the most impactful developments affecting workplace drug testing, employment decisions, and compliance obligations.

Note: These bills are progressing but have not passed at the time of this article’s publication.

Florida

Florida lawmakers are advancing multiple cannabis-related bills, including those directly addressing employer liability.

  • Florida House Bill 0689 (H 0689) and Senate Bill 1702 (S 1702).

Both bills would grant employers immunity from civil liability if action is taken against an employee or applicant when:

  • Cannabis use or possession occurs at the workplace;
  • The employee is impaired while performing job duties or responsibilities; or
  • The individual tests positive under a compliant drug testing program (per Florida statute 112.0455).

These bills are similar and are linked as such under the Florida legislature page. The hope is that by introducing identical or extremely similar bills in the House and Senate at the same time, the legislative process will be streamlined.

Additional expansion bills:

  • Florida House Bill 0719 (H 0719) – Expands medical cannabis law
  • Florida Senate Bill 1032 (S 1032) – Expands medical cannabis law
  • Florida Senate Bill 0776 (S 0776) – Authorizes limited home cultivation

Employer takeaway: Florida is reinforcing employer protections while expanding access—strong written policies and compliant testing procedures are critical.

Georgia

  • Georgia House Bill 1248 (HB 1248) – Recreational legalization (no employer provisions)
  • Georgia Senate Bill 220 (SB 220) – Renames low THC oil as medical cannabis and expands qualifying conditions

Employer takeaway: Recreational legalization proposals without workplace language can create ambiguity. Employers should clarify impairment standards and policy expectations.

Hawaii

Hawaii is considering both constitutional amendments and workplace protections:

  • Hawaii Senate Bill 2998 (SB 2998) – Prohibits employment discrimination against medical cannabis registry cardholders under certain conditions, but allows fit-for-duty testing in safety-sensitive roles under certain conditions.
  • Hawaii House Bill 1625 (HB 1625) – Legalization proposal that explicitly excludes workplace use protections; continent on specific changes at the federal level or a state constitutional amendment.

Additionally, the Hawaii legislature has proposed five bills to legalize recreational cannabis via a constitutional amendment. While these bills do not currently mention the workplace; if passed it is certain that employer guidance would be provided.

Employer takeaway: Anti-discrimination language tied to medical cannabis registry status is expanding nationally—policy language must distinguish between status and impairment.

Illinois

Illinois shifts focus to psychedelics and THC driving limits:

  • Illinois Senate Bill 2184 (SB 2184) – Psilocybin legalization; preserves employer authority to restrict controlled substance use.
  • Illinois Senate Bill 3214 (SB 3214) – Establishes THC driving limits within two hours of operating a vehicle.

Employer takeaway: Even in psychedelic expansion, lawmakers are preserving workplace drug policy authority.

Indiana

  • Indiana Senate Bill 0286 (SB 0286) – Legalizes medical and recreational cannabis. Explicitly protects employer zero-tolerance policies and clarifies that prohibiting work while under the influence is not unlawful discrimination.

Employer takeaway: Indiana provides clear statutory backing for employer drug-free workplace policies—when applied in a non-discriminatory manner.

Iowa

  • Iowa House File 620 (HF 620), House File 2085 (HF 2085)  – Psilocybin legalization; state employers shall treat an employee’s use of medical psilocybin the same as any prescribed controlled substance. State employees that fail a drug test due to psilocybin shall not be subject to adverse action without evidence that the individual was impaired due to their use of medical psilocybin (with certain limited exceptions that protect state employers).
  • Iowa House File 978 (HF 978) – Psilocybin legalization; prohibits adverse action solely for positive psilocybin test without evidence of impairment (with federal exemptions).
  • Iowa House File 2206 (HF 2206) – Recreational cannabis legalization; bars employment denial for lawful use but preserves discipline for impairment.

Employer takeaway: The “impairment vs. positive test” debate continues to intensify.

Kansas

  • Kansas House Bill 2678 (HB 2678) – Prohibits discrimination against medical marijuana patients absent valid business necessity.
  • Kansas House Bill 2679 (HB 2679) – Protects employer authority to prohibit use on property.

Employer takeaway: Expect more “business necessity” language in future statutes—documentation will be key.

Oklahoma

  • Oklahoma House Bill 1714 (HB 1714) – Employers cannot discriminate against applicants based on their use of cannabis off the job, or based on an employer-required drug test that has found non-psychoactive cannabis metabolites. Employers can base employment decisions on drug screening conducted through methods that do not screen for nonpsychoactive cannabis metabolites. This does not apply to certain federally regulated or safety-sensitive positions for which impairment while working would present a substantial risk of death.
  • Oklahoma House Bill 3127 (HB 3127) – Reinforces employer zero-tolerance authority and protects against wrongful discharge claims when policies are properly enforced.

Employer takeaway: Clear written policies remain your strongest legal defense.

Other States to Watch

Delaware, Massachusetts, Missouri, Nebraska, New Hampshire, New Jersey, Pennsylvania, South Carolina, Tennessee, Washington, and Wisconsin have all introduced legislation addressing the legal use of cannabis—whether for medical, recreational, or expanded access purposes.

Current Consulting will continue to monitor developments in these states and provide timely updates to help employers stay informed and complaint.

Emerging Trends Across States

Across all 30+ states introducing cannabis, hemp, or psychedelic-related bills, five themes are emerging:

  1. Shift from “positive test” to “impairment standard.”
  2. Expanded medical cannabis anti-discrimination protections.
  3. Explicit employer immunity clauses (Florida, Oklahoma, Indiana).
  4. Growing legalization of psilocybin with workplace carve-outs.
  5. Continued federal compliance exceptions for DOT-regulated and federally funded employers.

What Employers Should Do Now

If your organization operates in multiple states—or even a single state actively debating reform—you should:

  • Review and update drug-free workplace policies.
  • Clearly define impairment and testing triggers.
  • Confirm compliance with state-specific anti-discrimination provisions.
  • Re-evaluate pre-employment cannabis testing practices.
  • Train supervisors on reasonable suspicion and documentation standards.
  • Monitor federal developments regarding cannabis rescheduling.

Final Thought

The 2026 legislative session proves that cannabis and psychedelic policy is no longer just a criminal justice issue—it is a workplace compliance issue.

Employers who proactively adjust policies and training will be positioned to reduce litigation risk, maintain safety, and navigate the evolving legal landscape with confidence.

Need help ensuring your drug-free workplace policy aligns with 2026 cannabis employment laws? Conduct a compliance review before these bills become law.  Current Consulting Group’s team of policy writers are ready to tell you more about our services or subscribe to CurrentCompliance.org, our state drug testing laws online database. Click here to learn more about our subscription options. Subscribers receive monthly legislative updates to help them stay current.

© 2010-2026 Current Consulting Group, LLC. – No portion of this article may be reproduced, retransmitted, posted on a website, or used in any manner without the written consent of the Current Consulting Group, LLC. When permission is granted to reproduce this article in any way, full attribution to the author and copyright holder is required.